IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SAVOIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.063
EU - Europa 428
AS - Asia 229
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.059
CN - Cina 164
UA - Ucraina 142
IT - Italia 91
DE - Germania 63
FI - Finlandia 46
HK - Hong Kong 34
FR - Francia 27
GB - Regno Unito 27
IE - Irlanda 23
IN - India 19
IR - Iran 5
CA - Canada 4
TR - Turchia 4
BE - Belgio 2
PL - Polonia 2
SE - Svezia 2
SG - Singapore 2
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
JP - Giappone 1
RO - Romania 1
Totale 1.724
Salva come PNG Salva come JPEG
Città #
Fairfield 124
Jacksonville 106
Houston 90
Woodbridge 88
Ann Arbor 87
Chandler 82
Ashburn 73
Cambridge 56
Brescia 51
New York 47
Princeton 44
Wilmington 44
Nanjing 37
Seattle 36
Hong Kong 34
Beijing 33
Dearborn 30
Helsinki 29
Dublin 23
Lancaster 11
Nanchang 11
Hebei 10
Changsha 9
Des Moines 8
Jiaxing 8
Jinan 8
Kunming 8
Milan 8
San Diego 8
Shenyang 8
Pune 7
Leawood 6
San Mateo 6
Shanghai 6
San Donà Di Piave 5
Boardman 4
Guangzhou 4
Toronto 4
Verona 4
Ardabil 3
Hangzhou 3
Macerata 3
Ningbo 3
Tianjin 3
Turin 3
Auburn Hills 2
Brussels 2
Chicago 2
Fuzhou 2
Haikou 2
Kocaeli 2
London 2
Norwalk 2
Rho 2
San Francisco 2
San Giovanni in Persiceto 2
Warsaw 2
Zhengzhou 2
Alexandria 1
Augusta 1
Bath 1
Brooklyn 1
Buenos Aires 1
Cagliari 1
Caprino Veronese 1
Changchun 1
Corona 1
Cupertino 1
Frankfurt am Main 1
Fremont 1
Hanover 1
Harbin 1
Hefei 1
Leicester 1
Madrid 1
Monmouth Junction 1
Orange 1
Paris 1
Phoenix 1
Prescot 1
Sabz 1
Singapore 1
Sofia 1
Sydney 1
São Paulo 1
Taiyuan 1
Taizhou 1
Tokyo 1
Totale 1.331
Salva come PNG Salva come JPEG
Nome #
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 152
The D3 dopamine receptor: From structural interactions to function. 132
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 123
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 119
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 113
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 109
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 107
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 102
Role of dopamine D3R/nAChR heterodimeric complex in the regulation of dopaminergic neurons function. 70
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 68
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 66
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 66
D1 receptor signalling in basal ganglia function and dysfunctions. 66
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 65
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 63
Down-regulation of the D1R/Shp-2/Erk1/2 pathway ameliorates L-DOPA-induced dyskinesia in the 6-Hydroxy-Dopamine rat model of Parkinson's disease. 63
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 61
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 55
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 55
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 51
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 51
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensus 35
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 13
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 10
Totale 1.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201993 0 0 0 0 0 0 0 0 0 15 40 38
2019/2020442 69 11 13 43 19 58 50 49 24 63 19 24
2020/2021278 4 26 4 28 3 30 5 34 41 31 70 2
2021/2022195 21 37 5 2 0 3 13 8 9 27 18 52
2022/2023213 31 0 5 17 22 60 4 21 42 0 7 4
2023/2024202 16 5 21 24 13 70 4 5 37 7 0 0
Totale 1.815